V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003635 | 300002543 | 1.74 | 65.5 | Neo-adjuvant (N) | 2012-01-26 | 2014-04-28 | CISPLATIN + FLUOROURACIL | N | N | 300016277 | CISPLATIN + FLUOROURACIL |
| 300003636 | 300002543 | 1.57 | null | Curative (C) | 2016-07-19 | 2016-08-05 | Cisplatin +Fluorouracil (2 wk) | N | N | 300016277 | CISPLATIN + FLUOROURACIL |
| 300003637 | 300002543 | 1.84 | 42.6 | Curative (C) | null | 2015-10-10 | Cetuximab + Radiotherapy Load | N | Y | 300016277 | CETUXIMAB + RT |
| 300003638 | 300002543 | null | 74.3 | Curative (C) | 2014-11-03 | 2014-11-25 | Trial Unspecified | Y | N | 300016277 | TRIAL |
| 300003639 | 300002543 | 1.81 | 49.6 | Curative (C) | 2013-08-11 | 2013-09-08 | Cetuximab 7 day (Cycle 1) | N | null | 300016277 | CETUXIMAB |
| 300003640 | 300002544 | 1.78 | null | Neo-adjuvant (N) | 2016-10-14 | 2016-10-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016288 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003641 | 300002545 | 1.65 | 112 | Curative (C) | 2017-06-12 | 2017-06-21 | CETUXIMAB + RT | N | Y | 300016296 | CETUXIMAB + RT |
| 300003642 | 300002545 | 1.68 | 53.2 | Curative (C) | 2016-01-20 | 2016-01-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 300016296 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003643 | 300002546 | 1.6 | 85.7 | Adjuvant (A) | 2016-06-15 | 2016-07-10 | Capecitabine | N | N | 300016301 | CAPECITABINE |
| 300003644 | 300002547 | 1.6 | 46 | Neo-adjuvant (N) | 2016-02-04 | 2016-02-04 | CISPLATIN + FLUOROURACIL | N | N | 300016302 | CISPLATIN + FLUOROURACIL |
| 300003645 | 300002548 | null | 77.9 | Palliative (P) | 2016-07-07 | 2016-08-05 | CARBOPLATIN + PACLITAXEL | 02 | N | 300016303 | CARBOPLATIN + PACLITAXEL |
| 300003646 | 300002549 | 1.8 | 75 | Neo-adjuvant (N) | 2014-02-19 | 2014-02-20 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016307 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003647 | 300002550 | 1.71 | 51 | Neo-adjuvant (N) | 2017-07-07 | 2017-07-26 | CISPLATIN + FLUOROURACIL | 01 | N | 300016311 | CISPLATIN + FLUOROURACIL |
| 300003648 | 300002551 | null | 67.3 | Neo-adjuvant (N) | 2017-06-03 | 2017-06-10 | CISPLATIN + FLUOROURACIL | 2 | N | 300016318 | CISPLATIN + FLUOROURACIL |
| 300003649 | 300005971 | 1.61 | 69.3 | Palliative (P) | 2015-09-02 | 2015-09-02 | CISPLATIN + FLUOROURACIL | N | N | 300016330 | CISPLATIN + FLUOROURACIL |
| 300003650 | 300005971 | 1.8 | 67.3 | Curative (C) | 2013-12-21 | 2013-12-26 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016330 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003651 | 300002552 | 1.81 | 84 | Curative (C) | 2013-09-27 | 2013-10-18 | CETUXIMAB + RT | N | Y | 300016340 | CETUXIMAB + RT |
| 300003652 | 300002553 | 1.75 | 77 | Neo-adjuvant (N) | 2015-08-02 | 2015-08-24 | CISPLATIN + FLUOROURACIL | 2 | N | 300016341 | CISPLATIN + FLUOROURACIL |
| 300003653 | 300002554 | 1.66 | 99.7 | Neo-adjuvant (N) | 2014-11-07 | 2014-11-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016348 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003654 | 300002555 | 1.81 | 95.8 | Adjuvant (A) | 2014-08-15 | 2014-09-11 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016352 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003655 | 300002555 | null | null | Curative (C) | 2015-09-11 | 2015-09-13 | Trial Unspecified | N | null | 300016352 | TRIAL |
| 300003656 | 300002556 | 1.7 | null | Curative (C) | null | 2014-06-13 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300016355 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003657 | 300002557 | null | 58.4 | null | 2013-10-11 | 2013-10-12 | CETUXIMAB + RT | 02 | null | 300016360 | CETUXIMAB + RT |
| 300003658 | 300002558 | 1.8 | 82.3 | Curative (C) | 2016-09-27 | 2016-10-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300016364 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003659 | 300002559 | 1.65 | 104.6 | Neo-adjuvant (N) | 2016-07-14 | 2016-08-13 | CISPLATIN + FLUOROURACIL | 02 | N | 300016370 | CISPLATIN + FLUOROURACIL |
| 300003660 | 300002560 | 1.48 | 71.2 | Not known (9) | null | 2016-09-16 | CARBOPLATIN + PACLITAXEL | N | N | 300016378 | CARBOPLATIN + PACLITAXEL |
| 300003661 | 300002560 | 1.73 | 74 | Palliative (P) | 2015-03-30 | 2015-03-31 | Capecitabine | 02 | N | 300016378 | CAPECITABINE |
| 300003662 | 300002560 | 1.6 | 56.9 | Curative (C) | 2013-05-24 | 2013-05-31 | CETUXIMAB | N | Y | 300016378 | CETUXIMAB |
| 300003663 | 300002561 | 1.64 | 61 | Neo-adjuvant (N) | 2014-04-10 | 2014-05-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016385 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003664 | 300002562 | 1.64 | null | Palliative (P) | null | 2016-12-27 | CISPLATIN + FLUOROURACIL | N | N | 300016386 | CISPLATIN + FLUOROURACIL |
| 300003665 | 300002563 | 1.84 | 64.5 | null | 2016-05-27 | 2016-05-27 | CISPLATIN + FLUOROURACIL | 02 | null | 300016388 | CISPLATIN + FLUOROURACIL |
| 300003666 | 300002564 | 1.73 | 89 | null | 2013-08-01 | 2013-08-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016391 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003667 | 300002565 | 1.7 | 60.6 | Adjuvant (A) | 2013-09-01 | 2013-09-01 | Capecitabine | 2 | N | 300016394 | CAPECITABINE |
| 300003668 | 300002566 | null | null | Palliative (P) | 2013-08-28 | 2013-09-16 | Trial Unspecified | null | N | 300016396 | TRIAL |
| 300003669 | 300002567 | 1.66 | null | Palliative (P) | 2015-05-15 | 2015-05-18 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016399 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003670 | 300002567 | 1.71 | 151.2 | Adjuvant (A) | 2013-08-22 | 2013-08-31 | BILCAP TRIAL | N | N | 300016399 | TRIAL |
| 300003671 | 300002568 | 1.62 | 57.4 | Neo-adjuvant (N) | 2013-10-02 | 2013-10-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016404 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003672 | 300005975 | 1.86 | 102.4 | Palliative (P) | 2017-01-30 | 2017-02-19 | Trial Unspecified | N | Y | 300016412 | TRIAL |
| 300003673 | 300005975 | 1.58 | 71 | Curative (C) | 2015-08-30 | 2015-10-03 | Cetuximab + Radiotherapy Maint | N | Y | 300016412 | CETUXIMAB + RT |
| 300003674 | 300002569 | 1.67 | 42 | Palliative (P) | 2013-12-24 | 2013-12-25 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300016414 | CARBOPLATIN + PACLITAXEL |
| 300003677 | 300002571 | 1.7 | 66.15 | Palliative (P) | 2015-03-22 | 2015-04-19 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300016428 | CARBOPLATIN + PACLITAXEL |
| 300003678 | 300002572 | 1.6 | null | Adjuvant (A) | 2016-08-28 | 2016-09-09 | Capecitabine | 01 | null | 300016434 | CAPECITABINE |
| 300003679 | 300002573 | 1.75 | null | Neo-adjuvant (N) | 2017-01-10 | 2017-04-23 | Cisplatin +Fluorouracil (3 wk) | N | N | 300016438 | CISPLATIN + FLUOROURACIL |
| 300003680 | 300002574 | 1.52 | 90.6 | Curative (C) | null | 2015-08-13 | Cisplatin +Fluorouracil (3 wk) | 01 | N | 300016439 | CISPLATIN + FLUOROURACIL |
| 300003681 | 300002574 | 1.58 | 69.3 | Neo-adjuvant (N) | 2014-03-11 | 2014-03-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016439 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003682 | 300002575 | 1.61 | 66.2 | Neo-adjuvant (N) | 2013-03-12 | 2013-03-12 | Cisplatin + Docetaxel +Fluorouracil | Y | null | 300016451 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003683 | 300002576 | 1.73 | 80 | Neo-adjuvant (N) | 2014-03-08 | 2014-04-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300016455 | CISPLATIN + FLUOROURACIL |
| 300003684 | 300002577 | 1.83 | 86.7 | Not known (9) | 2016-02-09 | 2016-03-04 | BILCAP TRIAL | N | N | 300016458 | TRIAL |
| 300003685 | 300002578 | 1.86 | 95.6 | null | 2017-08-10 | 2017-09-10 | CISPLATIN + FLUOROURACIL | N | N | 300016461 | CISPLATIN + FLUOROURACIL |
| 300003686 | 300002579 | 1.8 | null | null | 2014-06-13 | 2014-06-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300016465 | CISPLATIN + DOCETAXEL + FLUOROURACIL |